Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.


Journal

NPJ genomic medicine
ISSN: 2056-7944
Titre abrégé: NPJ Genom Med
Pays: England
ID NLM: 101685193

Informations de publication

Date de publication:
07 Oct 2021
Historique:
received: 08 04 2021
accepted: 23 08 2021
entrez: 8 10 2021
pubmed: 9 10 2021
medline: 9 10 2021
Statut: epublish

Résumé

Despite recent advances in the prevention of cervical cancer, the disease remains a leading cause of cancer-related deaths in women worldwide. By applying the GISTIC2.0 and/or the MutSig2CV algorithms on 430 whole-exome-sequenced cervical carcinomas, we identified previously unreported significantly mutated genes (SMGs) (including MSN, GPX1, SPRED3, FAS, and KRT8), amplifications (including NFIA, GNL1, TGIF1, and WDR87) and deletions (including MIR562, PVRL1, and NTM). Subset analyses of 327 squamous cell carcinomas and 86 non-squamous cell carcinomas revealed previously unreported SMGs in BAP1 and IL28A, respectively. Distinctive copy number alterations related to tumors predominantly enriched for *CpG- and Tp*C mutations were observed. CD274, GRB2, KRAS, and EGFR were uniquely significantly amplified within the Tp*C-enriched tumors. A high frequency of aberrations within DNA damage repair and chromatin remodeling genes were detected. Facilitated by the large sample size derived from combining multiple datasets, this study reveals potential targets and prognostic markers for cervical cancer.

Identifiants

pubmed: 34620846
doi: 10.1038/s41525-021-00244-2
pii: 10.1038/s41525-021-00244-2
pmc: PMC8497615
doi:

Types de publication

Journal Article

Langues

eng

Pagination

82

Subventions

Organisme : V Foundation for Cancer Research (V Foundation)
ID : V2015-009
Organisme : V Foundation for Cancer Research (V Foundation)
ID : DVP2018-007
Organisme : Helse Vest (Western Norway Regional Health Authority)
ID : F-11486 (912227)
Organisme : Helse Vest (Western Norway Regional Health Authority)
ID : 27804
Organisme : Kreftforeningen (Norwegian Cancer Society)
ID : 190202

Informations de copyright

© 2021. The Author(s).

Références

Nat Struct Mol Biol. 2010 Nov;17(11):1324-9
pubmed: 20935634
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Nature. 2017 Mar 16;543(7645):378-384
pubmed: 28112728
Clin Cancer Res. 2009 Oct 1;15(19):5985-92
pubmed: 19789318
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36
pubmed: 30306584
Lancet. 2019 Jan 12;393(10167):169-182
pubmed: 30638582
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Gene. 2016 Jun 10;584(1):90-96
pubmed: 26992638
Nat Genet. 2020 Aug;52(8):800-810
pubmed: 32747824
Clin Cancer Res. 2004 Jan 15;10(2):572-80
pubmed: 14760079
Nature. 2014 Feb 20;506(7488):371-5
pubmed: 24390348
Int J Cancer. 2015 Aug 15;137(4):776-83
pubmed: 25626421
Nat Genet. 2013 Sep;45(9):977-83
pubmed: 23852168
J Cell Sci. 2014 Jan 15;127(Pt 2):267-75
pubmed: 24421310
Am J Clin Oncol. 2017 Dec;40(6):590-597
pubmed: 26083558
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Clin Cancer Res. 2015 Dec 1;21(23):5360-70
pubmed: 26080840
Cancer Treat Rev. 2016 Jan;42:30-40
pubmed: 26643553
Onco Targets Ther. 2018 Dec 21;12:41-49
pubmed: 30613151
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer. 2013 Nov 1;119(21):3776-83
pubmed: 24037752
Genome Biol. 2011;12(4):R41
pubmed: 21527027
Pathol Res Pract. 2019 Aug;215(8):152509
pubmed: 31255330
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
J Med Genet. 2019 Mar;56(3):186-194
pubmed: 30567904
Am J Obstet Gynecol. 2017 Oct;217(4):432.e1-432.e17
pubmed: 28599900
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Cell Rep. 2018 Apr 03;23(1):239-254.e6
pubmed: 29617664
Nat Cell Biol. 2019 Feb;21(2):152-161
pubmed: 30602726
Oncol Rep. 2017 Jun;37(6):3536-3542
pubmed: 28498431
J Int Med Res. 2020 Aug;48(8):300060520929170
pubmed: 32851895
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Oncogene. 2016 Aug 25;35(34):4423-36
pubmed: 26804164
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20007-12
pubmed: 18077431
Dis Markers. 2016;2016:6594016
pubmed: 27069297
Comp Biochem Physiol B Biochem Mol Biol. 2014 Feb;168:53-61
pubmed: 24269721

Auteurs

Mari K Halle (MK)

Department of Obstetrics and Gynaecology, Haukeland University Hospital, Bergen, Norway.
Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Aishwarya Sundaresan (A)

Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.

Jianqing Zhang (J)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Chandra Sekhar Pedamallu (CS)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Vinodh Srinivasasainagendra (V)

Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.

Jessica Blair (J)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Dewey Brooke (D)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Bjørn I Bertelsen (BI)

Department of Pathology, Haukeland University Hospital, Bergen, Norway.

Kathrine Woie (K)

Department of Obstetrics and Gynaecology, Haukeland University Hospital, Bergen, Norway.

Sadeep Shrestha (S)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Hemant Tiwari (H)

Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.

Yick Fu Wong (YF)

Department of Obstetrics and Gynecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.

Camilla Krakstad (C)

Department of Obstetrics and Gynaecology, Haukeland University Hospital, Bergen, Norway. camilla.krakstad@uib.no.
Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway. camilla.krakstad@uib.no.

Akinyemi I Ojesina (AI)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. ojesina@uab.edu.
O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. ojesina@uab.edu.
HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA. ojesina@uab.edu.

Classifications MeSH